You are here
Prof. Peter Haddad - Editorial Board, Schizophrenia Resource Centre
Peter Haddad is a Consultant in Community Psychiatry in Salford and an Honorary Clinical Professor at the University of Manchester, UK. His main clinical and research interests are the management of affective disorders and schizophrenia including the safety and side effects of psychiatric drugs. He has published widely and is joint editor of two textbooks. He was a member of the Guideline Development Group for the NICE 2006 Bipolar Guideline and the NICE 2009 Medicines Adherence Guideline. He has contributed to other treatment guidelines including the British Association for Psychopharmacology Guidelines on the treatment of Schizophrenia and Bipolar Disorder. He is an member of the editorial board of several international journals.
In the last 3 years Peter Haddad has received fees for lecturing and/or consultancy (including attending advisory boards) from Bristol Myers Squibb, Eli Lilly, Janssen-Cilag, Lundbeck, Otsuka, Quantum Pharmaceutical, Sunovion, Takeda, Teva, Roche and Servier. Several of these companies have provided support to attend conferences.